Smooth muscle antibodies (SMA) are associated with liver inflammation in autoimmune liver diseases, particularly autoimmune hepatitis. When the immune system produces SMA, it mistakenly targets and attacks smooth muscle cells within the liver. This immune response results in liver inflammation, which, if left untreated, can lead to progressive liver damage. The detection of SMA is an essential step in diagnosing these conditions and initiating appropriate treatment to reduce liver inflammation.